Table 2.
Clinical Characteristics of Patients
| Patient no. | Age (years) | Sex | SSc type | Early/late∗ | MRSS |
|---|---|---|---|---|---|
| Skin Immunostaining | |||||
| SSc1 | 65 | F | dcSSC | Early | 12 |
| SSc2 | 48 | F | dcSSc | Early | 21 |
| SSc3 | 52 | F | dcSSc | Early | 13 |
| SSc4 | 45 | F | dcSSc | Early | 9 |
| SSc5 | 40 | F | dcSSc | Early | 32 |
| SSc6 | 35 | F | dcSSc | Early | 10 |
| SSc7 | 44 | F | dcSSc | Early | 12 |
| SSc8 | 34 | F | dcSSc | Late | 32 |
| SSc9 | 46 | F | dcSSc | Late | 35 |
| SSc10 | 30 | F | dcSSc | Late | 4 |
| SSc11 | 60 | F | lcSSc | Late | 4 |
| SSc12 | 54 | F | dcSSc | Late | 13 |
| SSc13 | 43 | F | dcSSc | Early | 9 |
| SSc14 | 30 | F | dcSSc | Late | 18 |
| SSc15 | 43 | M | dcSSc | Early | 34 |
| SSc16 | 32 | F | dcSSc | Early | 31 |
| SSc17 | 56 | F | dcSSc | Early | 13 |
| SSc18 | 51 | F | dcSSc | Early | 11 |
| SSc19 | 44 | F | dcSSc | Early | 20 |
| SSc20 | 33 | M | dcSSc | Early | 13 |
| Lung Immunostaining | |||||
| SSc1 | 59 | F | NA | Late | |
| SSc2 | 46 | M | NA | Late | |
| SSc3 | 60 | M | lcSSc | Late | |
| SSc4 | 50 | F | dcSSc | Late | |
F, female; M, male; dcSSc, diffuse cutaneous SSc; lcSSc, limited cutaneous SSc; MRSS, modified Rodnan skin score; NA, not available.
∗
Early indicates <2 years from the first non-Raynaud’s disease manifestation.